ATC code L01
Abemaciclib
Accelerated approval
Aclarubicin
Adagrasib
Adenosine deaminase inhibitor
Aflibercept
Alitretinoin
Alkyl sulfonate
Alkylating antineoplastic agent
Alpelisib
Altretamine
Alvocidib
American Society of Health-System Pharmacists
Aminolevulinic acid
Aminopterin
Amrubicin
Amsacrine
Anagrelide
Anatomical Therapeutic Chemical Classification System
Anthracycline
Anthraquinone
Antifolate
Antimetabolite
Antineoplastic
Apoptosis
Arsenic trioxide
Asparaginase
Asparagine
Atrasentan
Axicabtagene ciloleucel
Azacitidine
Aziridine
Belinostat
Belotecan
Belzutifan
Bendamustine
Bexarotene
Biological half-life
Bisantrene
Bleomycin
Bortezomib
Brexucabtagene autoleucel
Busulfan
CAS Registry Number
CYP1A1
CYP3A
Cabazitaxel
Camptotheca
Camptothecin
Capecitabine
Carboplatin
Carboquone
Carfilzomib
Carmofur
Carmustine
Celecoxib
Cell-cycle nonspecific antineoplastic agents
ChEBI
ChEMBL
ChemSpider
Chemical formula
Chemotherapy
Chlorambucil
Chlormethine
Cholangiocarcinoma
Ciltacabtagene autoleucel
Cisplatin
Cladribine
ClinicalTrials.gov
Clinical trial
Clofarabine
CompTox Chemicals Dashboard
Copanlisib (data page)
Cositecan
Crisnatol
Crosslinking of DNA
Cyclin-dependent kinase
Cyclophosphamide
Cytarabine
DNA polymerase inhibitor
DNA replication
Dacarbazine
Dactinomycin
DailyMed
Daunorubicin
Daunorubicin/cytarabine
Decitabine
Demecolcine
Denileukin diftitox
Deoxyribonucleotide
Diarrhea
Dicycloplatin
Diffuse large B-cell lymphoma
Dihydrofolate reductase inhibitor
Docetaxel
Doi (identifier)
Doxifluridine
Doxorubicin
DrugBank
Drug class
Drug metabolism
Drug nomenclature
Drugs.com
Duvelisib
Efaproxiral
Eflornithine
Elesclomol
Elsamitrucin
Enasidenib
Endometrial cancer
Endothelin receptor antagonist
Entinostat
Enzyme inhibitor
Epacadostat
Epirubicin
Epothilone
Eribulin
Estramustine phosphate
Etirinotecan pegol
Etoglucid
Etoposide
Exatecan
Excretion
Farnesyltransferase inhibitor
Fast track designation
Floxuridine
Fludarabine
Fluorouracil
Follicular lymphoma
Food and Drug Administration
Fotemustine
Fuzuloparib
Gemcitabine
Gimatecan
Glasdegib
HER2/neu
Halogenation
Histone deacetylase inhibitor
Hydrazine
Hydroxycarbamide
Hyperglycemia
Hypertension
Hypomethylating agent
IMP dehydrogenase
IUPAC nomenclature of chemistry
Idarubicin
Idecabtagene vicleucel
Idelalisib
Ifosfamide
Imetelstat
Inavolisib
Infections
Intercalation (biochemistry)
International Chemical Identifier
Intravenous infusion
Irinotecan
Isocitrate dehydrogenase
Ivosidenib
Ixabepilone
Ixazomib
JSmol
KEGG
Lapatinib
Larotaxel
Leukopenia
Lifileucel
Lipoxygenase inhibitor
Lisocabtagene maraleucel
List of withdrawn drugs
Lomustine
Lonidamine
Losoxantrone
Lower respiratory tract infections
Lucanthone
Lurbinectedin
Lurtotecan
M phase
Mannosulfan
Marginal zone lymphoma
Masoprocol
Medication
MedlinePlus
Melphalan
Melphalan flufenamide
Menogaril
Mercaptopurine
Methotrexate
Methyl aminolevulinate
Microtubule
Mitobronitol
Mitoguazone
Mitomycins
Mitotane
Mitotic inhibitor
Mitoxantrone
Mitozolomide
Molar mass
Nadofaragene firadenovec
Nausea
Navitoclax
Nedaplatin
Nelarabine
Neutropenia
New drug application
Nimustine
Niraparib
Niraparib/abiraterone acetate
Nitrogen mustard
Nitrosourea
Non-Hodgkin lymphoma
Obecabtagene autoleucel
Oblimersen
Olaparib
Olutasidenib
Omacetaxine mepesuccinate
Oprozomib
Orphan drug
Ortataxel
Oxaliplatin
P110α
P110δ
PARP inhibitor
PMID (identifier)
Paclitaxel
Padeliporfin
Palbociclib
Panobinostat
Pegaspargase
Pemetrexed
Pentostatin
Pharmacokinetics
Phases of clinical research
Phosphodiesterase inhibitor
Phosphoinositide 3-kinase
Phosphoinositide 3-kinase inhibitor
Photodynamic therapy
Photosensitizer
Pipobroman
Pirarubicin
Pixantrone
Plasma protein binding
Platinum-based antineoplastic
Plicamycin
Plitidepsin
Pneumonitis
Podophyllum peltatum
Porfimer sodium
Porphyrin
Pralatrexate
Prednimustine
Prescription drug
Priority review
Procarbazine
Proteasome inhibitor
Protein kinase inhibitor
PubChem
Purine analogue
Pyrimidine analogue
R-CHOP
Rabacfosadine
Raltitrexed
Ranimustine
Receptor antagonist
Regulation of therapeutic goods
Retinoid
Retinoid X receptor
Ribociclib
Ribonucleotide reductase inhibitor
Rituximab
Romidepsin
Route of administration
Rubitecan
Rucaparib
S2CID (identifier)
S phase
Satraplatin
Seliciclib
Selinexor
Semustine
Sex steroid
Silatecan
Simplified molecular-input line-entry system
Sitimagene ceradenovec
Skin rashes
Sotorasib
Spindle poison
Streptomyces
Streptozotocin
Tabelecleucel
Tagraxofusp
Talaporfin
Talimogene laherparepvec
Taxane
Tazemetostat
Tebentafusp
Tegafur
Tegafur/gimeracil/oteracil
Temoporfin
Temozolomide
Teniposide
Tesetaxel
Testolactone
Thiopurine
Thiotepa
Thrombocytopenia
Thymidylate synthase inhibitor
Tiazofurin
Tiazofurine
Tigilanol tiglate
Tioguanine
Tipifarnib
Tisagenlecleucel
Topoisomerase inhibitor
Topotecan
Trabectedin
Trastuzumab
Treosulfan
Tretinoin
Triazene
Triaziquone
Triethylenemelamine
Trofosfamide
Type II topoisomerase
Type I topoisomerase
U.S. Food and Drug Administration
Umbralisib
Unique Ingredient Identifier
Uramustine
Valrubicin
Veliparib
Venetoclax
Verdinexor
Verteporfin
Vinblastine
Vinca alkaloid
Vincristine
Vindesine
Vinflunine
Vinorelbine
Vorasidenib
Vorinostat
Vosaroxin
WHO Model List of Essential Medicines
Zorubicin